N/A
N=34
Assessment of the Stroke Rehabilitation Assessment of Movement as a Clinical Tool
Stroke
Bottom Line
View on ClinicalTrials.gov: NCT00635661 ↗Enrolled (actual)
34
Serious AEs
0.0%
Results posted
Mar 2012
Primary outcome: Primary: Stroke Rehabilitation Assessment of Movement (STREAM) — 73.1 units on a scale
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- —
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- State University of New York - Upstate Medical University
- Primary completion
- Dec 2009
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Stroke Rehabilitation Assessment of Movement (STREAM) |
73.1 | — |
Summary
The Stroke Rehabilitation Assessment of Movement (STREAM) is a relatively new measurement tool, which measures specific movement deficits (impairments) caused by a stroke. The STREAM is used to evaluate recovery of voluntary movement and basic mobility following the onset of a stroke. Several important clinical measurement properties of the STREAM remain to be explored, including its ability to measure impairments and clinical change in acute rehabilitation patients in the USA. We hypothesize that the STREAM will be able to detect and quantify a statistically significant change in the motor abilities of stroke patients from admission to discharge. An additional aim of the study is to compare the STREAM with two accepted and widely used clinical measures of function and disability, the Stroke Impact Scale (SIS)and the Functional Independence Measure (FIM). By linking movement deficits that are commonly assessed by physical therapists with measures of function and disability, the impact of the movement deficits can be understood.
Eligibility Criteria
Inclusion Criteria
- comprehension of English
- age 18 and older
- first-time stroke
- receiving in-patient rehabilitation at the Rusk Institute of Rehabilitation Medicine, New York, NY
Exclusion Criteria
- hemorrhagic stroke
- brain stem or cerebellar infarct
- other pre-existing neurologic conditions
Data sourced from ClinicalTrials.gov (NCT00635661). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.